Clinical Trial

A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation

Name: A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation — clinical trial record (NCT07759154)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The primary purpose of this study is to evaluate the efficacy of centanafadine once daily (QD) extended-release (XR) capsules in adults with attention-deficit/hyperactivity disorder (ADHD) and emotional dysregulation (ED).

Trial Details

NCT Number	NCT07759154
Lead Sponsor	Otsuka Pharmaceutical Development & Commercialization, Inc.
Conditions	Attention-deficit/Hyperactivity Disorder, Emotional Dysregulation
Enrollment	80 participants
Start Date	2026-08-20
Primary Completion	2027-05-27 (estimated)
Study Completion	2027-05-27 (estimated)
Updated on ClinicalTrials.gov	2026-08-12